Spyre Therapeutics, Inc. (SYRE) Insider Trading

Name: Spyre Therapeutics, Inc. (SYRE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 3, 2026): King-Jones Heidy (See Remarks): Exercise/Conversion of 27,999 shares, $406.0K.

Get alerted when insiders trade SYRE

Email address

Loading company data...

Loading company details...